IBDEI0QP ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13174,0)
 ;;=V12.03^^87^830^61
 ;;^UTILITY(U,$J,358.3,13174,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13174,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,13174,1,5,0)
 ;;=5^Personal h/o Malaria
 ;;^UTILITY(U,$J,358.3,13174,2)
 ;;=^303395
 ;;^UTILITY(U,$J,358.3,13175,0)
 ;;=V10.63^^87^830^62
 ;;^UTILITY(U,$J,358.3,13175,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13175,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,13175,1,5,0)
 ;;=5^Personal h/o Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,13175,2)
 ;;=^295234
 ;;^UTILITY(U,$J,358.3,13176,0)
 ;;=V10.62^^87^830^64
 ;;^UTILITY(U,$J,358.3,13176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13176,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,13176,1,5,0)
 ;;=5^Personal h/o Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,13176,2)
 ;;=^295233
 ;;^UTILITY(U,$J,358.3,13177,0)
 ;;=V12.71^^87^830^67
 ;;^UTILITY(U,$J,358.3,13177,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13177,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,13177,1,5,0)
 ;;=5^Personal h/o Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,13177,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,13178,0)
 ;;=V11.0^^87^830^73
 ;;^UTILITY(U,$J,358.3,13178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13178,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,13178,1,5,0)
 ;;=5^Personal h/o Schizophrenia
 ;;^UTILITY(U,$J,358.3,13178,2)
 ;;=^295249
 ;;^UTILITY(U,$J,358.3,13179,0)
 ;;=V24.2^^87^830^82
 ;;^UTILITY(U,$J,358.3,13179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13179,1,4,0)
 ;;=4^V24.2
 ;;^UTILITY(U,$J,358.3,13179,1,5,0)
 ;;=5^Postpartum
 ;;^UTILITY(U,$J,358.3,13179,2)
 ;;=^114052
 ;;^UTILITY(U,$J,358.3,13180,0)
 ;;=V22.2^^87^830^83
 ;;^UTILITY(U,$J,358.3,13180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13180,1,4,0)
 ;;=4^V22.2
 ;;^UTILITY(U,$J,358.3,13180,1,5,0)
 ;;=5^Pregnancy Status
 ;;^UTILITY(U,$J,358.3,13180,2)
 ;;=^97923
 ;;^UTILITY(U,$J,358.3,13181,0)
 ;;=V70.0^^87^830^84
 ;;^UTILITY(U,$J,358.3,13181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13181,1,4,0)
 ;;=4^V70.0
 ;;^UTILITY(U,$J,358.3,13181,1,5,0)
 ;;=5^Routine Med Exam
 ;;^UTILITY(U,$J,358.3,13181,2)
 ;;=^295590
 ;;^UTILITY(U,$J,358.3,13182,0)
 ;;=V68.1^^87^830^85
 ;;^UTILITY(U,$J,358.3,13182,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13182,1,4,0)
 ;;=4^V68.1
 ;;^UTILITY(U,$J,358.3,13182,1,5,0)
 ;;=5^Rx Refill
 ;;^UTILITY(U,$J,358.3,13182,2)
 ;;=^295585
 ;;^UTILITY(U,$J,358.3,13183,0)
 ;;=V43.3^^87^830^86
 ;;^UTILITY(U,$J,358.3,13183,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13183,1,4,0)
 ;;=4^V43.3
 ;;^UTILITY(U,$J,358.3,13183,1,5,0)
 ;;=5^S/P Heart Valve Replacement
 ;;^UTILITY(U,$J,358.3,13183,2)
 ;;=^295440
 ;;^UTILITY(U,$J,358.3,13184,0)
 ;;=V45.01^^87^830^87
 ;;^UTILITY(U,$J,358.3,13184,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13184,1,4,0)
 ;;=4^V45.01
 ;;^UTILITY(U,$J,358.3,13184,1,5,0)
 ;;=5^S/P Pacer Placement
 ;;^UTILITY(U,$J,358.3,13184,2)
 ;;=^303419
 ;;^UTILITY(U,$J,358.3,13185,0)
 ;;=V77.91^^87^830^89
 ;;^UTILITY(U,$J,358.3,13185,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13185,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,13185,1,5,0)
 ;;=5^Screen for High Cholesterol
 ;;^UTILITY(U,$J,358.3,13185,2)
 ;;=^322093
 ;;^UTILITY(U,$J,358.3,13186,0)
 ;;=V76.44^^87^830^90
 ;;^UTILITY(U,$J,358.3,13186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13186,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,13186,1,5,0)
 ;;=5^Screen for Prostate Cancer
 ;;^UTILITY(U,$J,358.3,13186,2)
 ;;=^321548
 ;;^UTILITY(U,$J,358.3,13187,0)
 ;;=V73.89^^87^830^88
 ;;^UTILITY(U,$J,358.3,13187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13187,1,4,0)
 ;;=4^V73.89
